<DOC>
	<DOCNO>NCT02104037</DOCNO>
	<brief_summary>The purpose study investigate transfer liraglutide blood cerebrospinal fluid .</brief_summary>
	<brief_title>Liraglutide Spinal Fluid</brief_title>
	<detailed_description />
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Type 2 diabetes treat liraglutide 1.8 mg 1 month 5 % weight loss</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>